Nifty's short-term trend has turned bearish, with the next support seen in the 24,900-25,000 range. On the upside, the former ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...